PRICE INCREASES BY CATEGORY

• 2.41%: Overall average projected price change
• 3.34%: Indirect spend and purchased services
• 2.02%: Medical products overall
• 2.58%: Medical and surgical products
  • 2.36%: Medical supplies
  • 3.28%: Surgical supplies
• 1.68%: Laboratory
  • 1.58%: Equipment
  • 1.76%: Consumables
• 2.08%: Capital and imaging equipment
  • 2.31%: Medical/capital equipment
  • 1.7%: Imaging equipment
• 1.68%: Physician preference items

4 FACTORS DRIVING ELEVATED INFLATION PROJECTIONS

1. Rising costs for raw materials
2. Cost pressures for freight and shipping
3. Tariffs, both current and potential
4. Inflation, influenced by volatility in global trade and supply chain conditions

4 FACTORS SHAPING FOOD PROCUREMENT IN HEALTHCARE

1. Tariff-driven cost increases
2. Rising demand for specialized nutrition
3. Economic uncertainty and shifting consumer behavior
4. Demographic and sector-specific growth 
   
   

3 FORCES INCREASING HEALTHCARE CONSTRUCTION SPEND

1. Escalating labor costs driven by persistent workforce shortages
2. Sustained inflation in construction materials
3. Prolonged lead times for products and equipment

PROJECTED DRUG PRICE INFLATION RATES

• 3.35%: Overall drug price increase
  • 2.41%: Contract products
  • 3.79%: Non-contract products
• 3.35%: Ambulatory care
• 3.93%: Pediatrics
• 3.30%: Ambulatory care, self-administered drugs
• 3.41%: Ambulatory care, provider-administered drugs
• 3.80%: Ambulatory care, specialty and complex medications

INCREASE BY THERAPEUTIC AREA

• 3.85%: Keytruda, Darzalex Faspro, Opdivo
  • Represents 23.62% of the Vizient and Provista pharmacy program
• 3.67%: Humira, Stelara, Skyrizi, Dupixent
  • 24.83% of the pharmacy program
• 4.19%: Biktarvy, Prevnar-20, Veklury
  • 10.42% of the pharmacy program
• 1.82%: Ozempic, Mounjaro, Prolia, Jardiance
  • 10.80% of the pharmacy program

TOP 3 AREAS OF CAPITAL EQUIPMENT SPEND FOR PROVISTA AND VIZIENT CLIENTS

1. 16.0%: Endoscopy equipment
2. 9.1%: Ultrasound equipment
3. 7.8%: Patient monitoring equipment

Note: Projections represent the best estimate of price changes for pharmaceuticals, supply chain products and materials, capital equipment and purchased services between Jan 1, 2026, and December 31, 2026. Get a copy of the Outlook.